Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker

  • Authors:
    • Shinei Kudo
    • Jun-Ichi Tanaka
    • Hiroshi Kashida
    • Yoshiro Tamegai
    • Shungo Endo
    • H. Yamano
  • View Affiliations

  • Published online on: May 1, 2002     https://doi.org/10.3892/or.9.3.635
  • Pages: 635-638
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In the present study, curatively resected patients of colorectal cancer at pTNM stages II and III were selected. Patients receiving postoperative combined PSK, a protein-bound polysaccharide, and fluoropyrimidine therapy (PSK + chemotherapy group) were compared with patients receiving postoperative chemotherapy alone (chemotherapy group) during the same period of study. Three-year disease-free survival rates were evaluated and the postoperative changes of serum type IV collagen level were investigated. The results confirmed a significant improvement of the three-year disease-free survival rate in the PSK + chemotherapy group compared to the chemotherapy group, suggesting that PSK is useful as postoperative prognosis control including relapse prevention for colorectal cancers at pTNM stage II and III. Analysis of the postoperative changes of serum type IV collagen level showed significantly higher levels in the chemotherapy group than in the PSK + chemotherapy group, and this tendency was sustained for 12 months after surgery. This observation is speculated to be caused by inhibition of vascular basement membrane destruction by PSK, leading to inhibition of release of type IV collagen into the blood. These results indicated a possibility that combined PSK and chemotherapy inhibited metastasis, thereby reducing the risk of relapse and leading to improvement of the three-year disease-free survival rate.

Related Articles

Journal Cover

May-June 2002
Volume 9 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kudo S, Tanaka J, Kashida H, Tamegai Y, Endo S and Yamano H: Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker. Oncol Rep 9: 635-638, 2002
APA
Kudo, S., Tanaka, J., Kashida, H., Tamegai, Y., Endo, S., & Yamano, H. (2002). Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker. Oncology Reports, 9, 635-638. https://doi.org/10.3892/or.9.3.635
MLA
Kudo, S., Tanaka, J., Kashida, H., Tamegai, Y., Endo, S., Yamano, H."Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker". Oncology Reports 9.3 (2002): 635-638.
Chicago
Kudo, S., Tanaka, J., Kashida, H., Tamegai, Y., Endo, S., Yamano, H."Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker". Oncology Reports 9, no. 3 (2002): 635-638. https://doi.org/10.3892/or.9.3.635